Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSPHERBST, R. S.BAAS, P.KIM, D-W.FELIP, E.PEREZ-GRACIA, J. L.HAN, J-Y.MOLINA, J.KIM, J-H.ARVIS, C. DubosAHN, M-J. A.MAJEM, M.FIDLER, M. J.CASTRO JR., G. DeGARRIDO, M.SHENTU, Y.LUBINIECKI, G. M.GARON, E. B.2017-05-192017-05-192016ANNALS OF ONCOLOGY, v.27, suppl.6, 20160923-7534https://observatorio.fm.usp.br/handle/OPI/19829engrestrictedAccessPembrolizumab (pembro) vs docetaxel (doce) for previously treated, PD-L1-expressing NSCLC: Updated outcomes of KEYNOTE-010conferenceObjectCopyright OXFORD UNIV PRESS10.1093/annonc/mdw435.47Oncology1569-8041